Sign in

MCUJF on OTC

MEDICURE INC

MEDICURE INC is a Canadian pharmaceutical preparations company based in Winnipeg.2 Its shares trade on OTC under the symbol MCUJF.2

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with MindWalk, PyroGenesis Canada Inc. or Adastra Holdings Ltd., or pick any stock.

  • TickerMCUJF on OTC2
  • IndustryPharmaceutical Preparations2
  • HeadquartersWinnipeg, Canada2
  • Incorporated inManitoba, Canada3
  • Business addressSuite 2, 1250 Waverley Street, Winnipeg, R2C 0A13
  • Filer categoryNon-accelerated filer3
  • Legal formShare corporations (including professional corporations)2
  • LEI9845007T999BF377B6272
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered address2-1250 WAVERLEY ST, R3T 6C6 Winnipeg, Canada2
  • Registered withCompanies Office (Province of Manitoba), 41638862

See how the biggest companies compare on our leaderboards

On December 22, 1999, the Company was formed by the amalgamation of Medicure Inc. with Lariat Capital Inc. pursuant to the provisions of the Business Corporations Act (Alberta). The Company was continued from Alberta to the federal jurisdiction by Certificate of Continuance issued pursuant to the provisions of the Canada Business Corporations Act on February 23, 2000.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from. Figures are in CAD, the currency the company reports in.

Key numbers, fiscal 2024

59.7%Gross margin5
-4.7%Net margin5
1.0%Revenue growth, 20245
-5.0%Return on equity5

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Retail and Mail Order Pharmacy brought in 70% of the revenue MEDICURE INC broke down this way in fiscal 2025.

  1. Retail and Mail Order Pharmacy20.3M CAD670%up 87% from 2024
  2. Marketing and Distribution of Commercial Products8.6M CAD630%down 23% from 2024
Business segments by year
Business segments20242025
Retail and Mail Order Pharmacy10.8M CAD20.3M CAD
Marketing and Distribution of Commercial Products11.1M CAD8.6M CAD

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue40¢8.8M CAD
  • Research and development14¢3.1M CAD
  • Other costs45¢9.8M CAD
  • Income tax1¢256.0K CAD

Out of 21.9M CAD in revenue.5 The company lost money this year.

Where each dollar of operating cash went, fiscal 2024

  • Kept or used elsewhere100¢1.4M CAD

Out of 1.4M CAD of cash from operations.5

Financial statements

Revenue78910521.9M CAD in 2024−25% since 2018
010.0M CAD20.0M CAD30.0M CAD2018: 29.1M CAD29.1M CAD20182019: 20.2M CAD20.2M CAD2019−31%2020: 11.6M CAD11.6M CAD2020−42%2021: 21.7M CAD21.7M CAD2021+87%2022: 23.1M CAD23.1M CAD2022+6%2023: 21.7M CAD21.7M CAD2023−6%2024: 21.9M CAD21.9M CAD2024+1%
Gross profit78910513.1M CAD in 2024−48% since 2018
010.0M CAD20.0M CAD30.0M CAD2018: 25.0M CAD25.0M CAD20182019: 12.9M CAD12.9M CAD2019−48%2020: 5.1M CAD5.1M CAD2020−60%2021: 12.7M CAD12.7M CAD2021+148%2022: 16.1M CAD16.1M CAD2022+26%2023: 14.0M CAD14.0M CAD2023−13%2024: 13.1M CAD13.1M CAD2024−6%
Net income789105-1.0M CAD in 2024
-20.0M CAD-10.0M CAD010.0M CAD2018: 3.9M CAD3.9M CAD20182019: -19.8M CAD-19.8M CAD20192020: -6.8M CAD-6.8M CAD2020−65%2021: -727.0K CAD-727.0K CAD2021−89%2022: 1.4M CAD1.4M CAD20222023: -922.0K CAD-922.0K CAD20232024: -1.0M CAD-1.0M CAD2024+13%

Every line of the income statement as filed: the last 3 fiscal years, latest first.6

Period ending2025-12-312024-12-312023-12-31
Product sales, net28.9M CAD21.9M CAD21.7M CAD
Cost of goods sold17.1M CAD8.8M CAD7.7M CAD
Gross profit11.7M CAD13.1M CAD14.0M CAD
Selling10.5M CAD8.0M CAD8.3M CAD
General and administrative5.0M CAD4.8M CAD4.1M CAD
Research and development3.2M CAD3.1M CAD2.4M CAD
Total expense18.6M CAD15.8M CAD14.8M CAD
Other income0 CAD-1.9M CAD0 CAD
Total Other income0 CAD-1.9M CAD0 CAD
Finance income, net-122.0K CAD-165.0K CAD-65.0K CAD
Foreign exchange loss, net123.0K CAD71.0K CAD108.0K CAD
Total Finance costs (income)1.0K CAD-94.0K CAD43.0K CAD
Net (loss) income before income taxes-6.9M CAD-783.0K CAD-897.0K CAD
Current-208.0K CAD-256.0K CAD-25.0K CAD
Deferred0 CAD0 CAD0 CAD
(Expense) recovery-208.0K CAD-256.0K CAD-25.0K CAD
Net loss-7.1M CAD-1.0M CAD-922.0K CAD
Exchange differences on translation of foreign subsidiaries:-908.0K CAD1.7M CAD-531.0K CAD
Comprehensive Income (loss)-8.0M CAD686.0K CAD-1.5M CAD
Basic-0.68 CAD-0.10 CAD-0.09 CAD
Diluted-0.68 CAD-0.10 CAD-0.09 CAD

Compare MEDICURE INC with another company

What it owns

What MEDICURE INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net955.0K CAD5 Dec 31, 2024736.0K CAD5 Dec 31, 2023+29.8%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents7.2M CAD5 Dec 31, 20246.4M CAD5 Dec 31, 2023+12.9%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill3.4M CAD5 Dec 31, 20243.1M CAD5 Dec 31, 2023+8.8%
Intangible assets, net (excluding goodwill)9.4M CAD5 Dec 31, 20248.9M CAD5 Dec 31, 2023+4.6%

Inventory

ItemLatestA year beforeChange
Inventory, total3.3M CAD5 Dec 31, 20242.9M CAD5 Dec 31, 2023+13.2%

Timeline

  1. Sep 15, 1997Founded MEDICURE INC is founded2

Filings

63 filings to the SEC since October 2021: 5 annual reports, 58 other. The latest 20:

  1. Aug 19, 20266-K EDGAR
  2. Aug 19, 20266-K EDGAR
  3. May 21, 20266-K EDGAR
  4. May 21, 20266-K EDGAR
  5. May 21, 20266-K EDGAR
  6. Apr 24, 20266-K EDGAR
  7. Apr 24, 202620-F EDGAR
  8. Apr 23, 20266-K EDGAR
  9. Nov 19, 20256-K EDGAR
  10. Nov 19, 20256-K EDGAR
  11. Nov 14, 20256-K EDGAR
  12. Aug 21, 20256-K EDGAR
  13. Aug 21, 20256-K EDGAR
  14. Aug 21, 20256-K EDGAR
  15. Jun 18, 20256-K EDGAR
  16. May 21, 20256-K EDGAR
  17. Apr 28, 20256-K EDGAR
  18. Apr 25, 202520-F EDGAR
  19. Apr 23, 20256-K EDGAR
  20. Apr 11, 20256-K EDGAR

The 63 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How MEDICURE INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARMEDICURE INC1
  • CIK0001133519
  • Filer statusNon-accelerated filer not an emerging growth company; not a shell company4
  • Incorporated inCanada4
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business addressSuite 2, 1250 Waverley Street, Winnipeg, Canada R2C 0A1, Manitoba, Canada1
  • Phone204-487-74121
  • Shares outstanding10,436,313 shares as of Dec 31, 20254
  • AuditorErnst & Young LLP, Winnipeg, Canada PCAOB ID 12634
  • On EDGAR sinceOct 29, 20021
  • Filings481 in all: 6-K (423), 20-F (25), SC 13G (5), SC 13G/A (4), F-10/A (3), F-X (3), F-10 (2), REGDEX (2)1
    All 20 form types

    SC 13D (2), UPLOAD (2), 20-F/A (1), 20FR12G/A (1), 25 (1), 6-K/A (1), 8-A12B (1), CB (1), CERTAMX (1), CORRESP (1), NT 20-F (1), S-8 (1)

  • Latest filingsAnnual report (20-F) Apr 24, 2026

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12